Uses of Xofluza

Xofluza contains the active ingredient Baloxavir Marboxil, which is used in the treatment of influenza symptoms caused by the Influenza virus in patients with new onset of symptoms within 48 hours. Note that the active ingredient Baloxavir marboxil in Xofluza is not used to treat the common cold. In addition to its therapeutic potential, Xofluza is also effective in preventing flu symptoms in people who have been in contact with confirmed influenza patients.
Xofluza medicine is only used for adult patients and children over 12 years old with a weight of at least 40kg.
An extremely important issue is that Xofluza is not a substitute for annual flu vaccination. The Centers for Disease Control and Prevention (CDC) recommends that people, especially those at high risk, get a flu shot every year to increase their protection against new strains of influenza virus.

In addition to the active ingredient Baloxavir Marboxil, Xofluza contains some inactive ingredients and this may cause allergic reactions or other problems in susceptible people. Patients should follow all instructions for taking Xofluza from the manufacturer and their doctor's instructions. Patients should inform the treating physician of all medical history, history of allergies and a list of all medications being taken. Patients should not use Xofluza if there is a background or previous history of allergy to Baloxavir marboxil. At the same time, patients who are pregnant or planning to become pregnant should tell their doctor before taking Xofluza. Influenza virus infection during pregnancy can cause serious complications that can affect the health of both mother and unborn baby, so the benefits of flu treatment with Xofluza may outweigh any risks. any risk to the unborn baby. The Centers for Disease Control and Prevention (CDC) recommends that pregnant women get a flu shot at any time during the first three months of pregnancy to protect themselves and their unborn baby from the flu virus. Inform the treating physician if the patient is breast-feeding before taking Xofluza.

Patients need to use Xofluza with the correct dosage and usage as prescribed by the doctor. In addition, it is necessary to refer to and follow the manufacturer's instructions for use of the drug accompanying the product.
Xofluza is recommended to be used only once with a dose dependent on the patient's weight. Xofluza may be available as a tablet or an oral suspension. Patients should use the recommended dose and do not share Xofluza with others. The best time to take Xofluza is within 48 hours of the patient's flu symptoms (such as fever, chills, muscle aches, sore throat, runny or stuffy nose). Xofluza may not be effective if a patient has had flu symptoms for more than 48 hours.
In the case of using Xofluza to prevent influenza, patients should take the drug as soon as possible after coming into contact with someone infected with the virus.
Xofluza can be taken before or after meals. However, patients should not take Xofluza with fresh milk, yogurt or calcium-fortified juices. Also, avoid taking Xofluza with laxatives, stomach antacids, or vitamin/mineral supplements that contain aluminum, calcium, magnesium, iron, selenium, or zinc.
Patients should contact their treating doctor if flu symptoms do not improve or tend to get worse despite taking Xofluza exactly as directed.
Store Xofluza tablets in the manufacturer's packaging, at room temperature, away from moisture and high temperatures.

Usual recommended dose for adults with flu symptoms:
Weight less than 80kg: 40mg orally as a single dose; Weight 80kg or more: 80mg taken once only. Recommended dose of Xofluza for the prevention of influenza in adults:
Weight less than 80kg: 40mg orally as a single dose Weight at least 80kg: 80mg orally as a single dose. The recommended dose of Xofluza for the treatment of influenza in children 12 years of age and older:
Weight less than 80kg: 40mg orally as a single dose; Weight over 80kg: 80mg of Xofluza taken as a single dose. Recommended dose of Xofluza to prevent influenza in children over 12 years old:
Weight less than 80kg: 40mg orally as a single dose; Weight over 80kg: 80mg orally as a single dose.

Patients should get emergency medical help if there are signs of an allergic reaction to Xofluza such as hives, difficulty breathing, swelling of the face, lips, tongue or throat.
Common side effects of Xofluza may include:
Cough, feeling of tightness in the chest; Nausea; Diarrhea; Headache; Runny or stuffy nose.

Patients already taking Xofluza should consult their doctor before receiving a live attenuated influenza vaccine (such as the FluMist nasal spray vaccine). Baloxavir marboxil may interfere with the effectiveness of the FluMist vaccine, making it less effective at preventing influenza.
Drug interactions can change the way Xofluza works or increase your risk of serious side effects. Patients make a list of all the products they are taking (including prescription drugs, over-the-counter drugs, and herbal products) and share it with their doctor and pharmacist.
In summary, Xofluza contains the active ingredient Baloxavir Marboxil, which is used in the treatment of influenza symptoms caused by the Influenza virus in patients with new onset of symptoms within 48 hours. Patients need to strictly follow the doctor's instructions to achieve the best treatment effect and avoid unwanted side effects.
Follow Vinmec International General Hospital website to get more health, nutrition and beauty information to protect the health of yourself and your loved ones in your family.

References: drugs.com, webmd.com, xofluza.com